BioAlpha Holdings
Posted: Mon Sep 11, 2017 9:04 am
not vested
Stock on Radar - HLIB Retail Research
Trading Buy: BIOHLDG - 0179
(Last price: RM0.255, Potential upside +19.6%)
Company Profile
Listed in Apr 2015, BIOHLDG is a home-grown integrated health supplements company, producing a variety of health supplements in herbal and non-herbal (halal & non-halal) based. About 60% of group revenue is from house brands and its best sellers include tiger milk mushroom, cordyceps sinensis, tongkat ali and collagen beauty products
Trading Catalyst
Trading at cheap 10.3x P/E18 (ex-cash), BIOHLDG is an up-and-coming integrated health supplement group with strong inhouse R&D, supported by upstream into farming as well as downstream into retail pharmacy.
Tapping into strong regional markets growth in China and Indonesia.
Positive for a triangle breakout to test RM0.285-0.305 levels.
Technical View
Resistance: RM0.270 / RM0.285 / RM0.305
Support: RM0.245 / RM0.240
Cut loss: RM0.235
Key Financial Stats
Trading at 10.3x FY18 P/E (ex-cash), 31% below peers
Strong EPS CAGR of 37% from FY16-19.
Source: Bloomberg, HLIB
Stock on Radar - HLIB Retail Research
Trading Buy: BIOHLDG - 0179
(Last price: RM0.255, Potential upside +19.6%)
Company Profile
Listed in Apr 2015, BIOHLDG is a home-grown integrated health supplements company, producing a variety of health supplements in herbal and non-herbal (halal & non-halal) based. About 60% of group revenue is from house brands and its best sellers include tiger milk mushroom, cordyceps sinensis, tongkat ali and collagen beauty products
Trading Catalyst
Trading at cheap 10.3x P/E18 (ex-cash), BIOHLDG is an up-and-coming integrated health supplement group with strong inhouse R&D, supported by upstream into farming as well as downstream into retail pharmacy.
Tapping into strong regional markets growth in China and Indonesia.
Positive for a triangle breakout to test RM0.285-0.305 levels.
Technical View
Resistance: RM0.270 / RM0.285 / RM0.305
Support: RM0.245 / RM0.240
Cut loss: RM0.235
Key Financial Stats
Trading at 10.3x FY18 P/E (ex-cash), 31% below peers
Strong EPS CAGR of 37% from FY16-19.
Source: Bloomberg, HLIB